TORONTO, ONTARIO–(Marketwired – June 28, 2017) – Trillium Therapeutics Inc. (TSX:TRIL)(NASDAQ:TRIL), a clinical stage immuno-oncology company developing innovative therapies for [...]
TORONTO, ONTARIO–(Marketwired – June 28, 2017) – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSX VENTURE:FIRE) is pleased to announce […]